How many institutions held BMGL - Basel Medical Group Ltd - Ordinary Shares with no par value in Q2 2025?

6 institutional investors reported BMGL - Basel Medical Group Ltd - Ordinary Shares with no par value for Q2 2025. Use the holders table for investor-level position and value details.

Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL)

Q: What does CUSIP G0864B103 represent in this 13F holders report?

CUSIP G0864B103 is the security identifier for BMGL - Basel Medical Group Ltd - Ordinary Shares with no par value used to aggregate holder disclosures.

CUSIP: G0864B103

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Ordinary Shares with no par value
Shares outstanding: 18,772,286
Total 13F shares: 124,340
Share change: +110,416
Total reported value: $221,398
Price per share: $1.78
Number of holders: 6
Value change: +$196,613
Number of buys: 5

Quarterly Holders Quick Answers

What is CUSIP G0864B103?
CUSIP G0864B103 identifies BMGL - Basel Medical Group Ltd - Ordinary Shares with no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025

Recent filing periods for CUSIP G0864B103:

Q4 2025 Q3 2025 Q2 2025

Institutional Holders of Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL) as of Q2 2025

As of 30 Jun 2025, Basel Medical Group Ltd - Ordinary Shares with no par value (BMGL) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 124,340 shares. The largest 6 holders included HRT FINANCIAL LP, Virtu Financial LLC, Marex Group plc, UBS Group AG, BARCLAYS PLC, and Tower Research Capital LLC (TRC). This page lists 6 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.